Fractyl Health Statistics
Total Valuation
Fractyl Health has a market cap or net worth of $58.63 million. The enterprise value is $72.23 million.
| Market Cap | 58.63M |
| Enterprise Value | 72.23M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026, after market close.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Fractyl Health has 13.26 million shares outstanding. The number of shares has increased by 168.74% in one year.
| Current Share Class | 13.26M |
| Shares Outstanding | 13.26M |
| Shares Change (YoY) | +168.74% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 47.08% |
| Float | 12.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.15
| Current Ratio | 3.15 |
| Quick Ratio | 3.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -74.57% |
| Return on Invested Capital (ROIC) | -104.67% |
| Return on Capital Employed (ROCE) | -129.67% |
| Weighted Average Cost of Capital (WACC) | 8.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.06M |
| Employee Count | 100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.69% in the last 52 weeks. The beta is 2.42, so Fractyl Health's price volatility has been higher than the market average.
| Beta (5Y) | 2.42 |
| 52-Week Price Change | -73.69% |
| 50-Day Moving Average | 7.34 |
| 200-Day Moving Average | 9.66 |
| Relative Strength Index (RSI) | 29.33 |
| Average Volume (20 Days) | 186,674 |
Short Selling Information
The latest short interest is 2.70 million, so 20.33% of the outstanding shares have been sold short.
| Short Interest | 2.70M |
| Short Previous Month | 2.22M |
| Short % of Shares Out | 20.33% |
| Short % of Float | 22.20% |
| Short Ratio (days to cover) | 1.65 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -85.89M |
| Pretax Income | -105.65M |
| Net Income | -105.65M |
| EBITDA | -84.77M |
| EBIT | -85.89M |
| Earnings Per Share (EPS) | -$9.71 |
Balance Sheet
The company has $47.14 million in cash and $60.74 million in debt, with a net cash position of -$13.60 million or -$1.02 per share.
| Cash & Cash Equivalents | 47.14M |
| Total Debt | 60.74M |
| Net Cash | -13.60M |
| Net Cash Per Share | -$1.02 |
| Equity (Book Value) | -1.67M |
| Book Value Per Share | -0.13 |
| Working Capital | 33.87M |
Cash Flow
In the last 12 months, operating cash flow was -$82.43 million and capital expenditures -$11,000, giving a free cash flow of -$82.44 million.
| Operating Cash Flow | -82.43M |
| Capital Expenditures | -11,000 |
| Depreciation & Amortization | 1.13M |
| Net Borrowing | -486,000 |
| Free Cash Flow | -82.44M |
| FCF Per Share | -$6.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Fractyl Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -168.74% |
| Shareholder Yield | -168.74% |
| Earnings Yield | -180.19% |
| FCF Yield | -140.61% |
Analyst Forecast
The average price target for Fractyl Health is $60.40, which is 1,266.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.40 |
| Price Target Difference | 1,266.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 5, 2026. It was a reverse split with a ratio of 1:12.
| Last Split Date | Oct 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |